Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Cancer Research

Long-Term Visual Outcome After Chemotherapy for Optic Pathway Glioma in Children: Site and Age Are Strongly Predictive

Cancer

Cancer Research

Oncology

2015

English

The Cognitive Effects of Endocrine Therapy in Survivors of Breast Cancer: A Prospective Longitudinal Study Up to 6 Years After Treatment

English

Severity of Reduced Bone Mineral Density and Risk of Fractures in Long‐term Survivors of Childhood Leukemia and Lymphoma Undergoing Guideline‐recommended Surveillance for Bone Health

English

Preventable and Mitigable Adverse Events in Cancer Care: Measuring Risk and Harm Across the Continuum

English

Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

English

Second-Opinion Interpretations of Neuroimaging Studies by Oncologic Neuroradiologists Can Help Reduce Errors in Cancer Care

English

Phase 2 Study Evaluating the Combination of Sorafenib and Temsirolimus in the Treatment of Radioactive Iodine-Refractory Thyroid Cancer

English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

English

Residence Proximity to Benzene Release Sites Is Associated With Increased Incidence of Non-Hodgkin Lymphoma

English

A Phase 2 and Biomarker Study of Cabozantinib in Patients With Advanced Cholangiocarcinoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Cancer Research

Long-Term Visual Outcome After Chemotherapy for Optic Pathway Glioma in Children: Site and Age Are Strongly Predictive

The Cognitive Effects of Endocrine Therapy in Survivors of Breast Cancer: A Prospective Longitudinal Study Up to 6 Years After Treatment

Severity of Reduced Bone Mineral Density and Risk of Fractures in Long‐term Survivors of Childhood Leukemia and Lymphoma Undergoing Guideline‐recommended Surveillance for Bone Health

Preventable and Mitigable Adverse Events in Cancer Care: Measuring Risk and Harm Across the Continuum

Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Second-Opinion Interpretations of Neuroimaging Studies by Oncologic Neuroradiologists Can Help Reduce Errors in Cancer Care

Phase 2 Study Evaluating the Combination of Sorafenib and Temsirolimus in the Treatment of Radioactive Iodine-Refractory Thyroid Cancer

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Residence Proximity to Benzene Release Sites Is Associated With Increased Incidence of Non-Hodgkin Lymphoma

A Phase 2 and Biomarker Study of Cabozantinib in Patients With Advanced Cholangiocarcinoma